Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function. / Albrethsen, Jakob; Johannsen, Trine Holm; Jørgensen, Niels; Frederiksen, Hanne; Sennels, Henriette P.; Jorgensen, Henrik Loevendahl; Fahrenkrug, Jan; Petersen, Jorgen Holm; Linneberg, Allan; Nordkap, Loa; Bang, Anne Kirstine; Andersson, Anna-Maria; Juul, Anders.

I: Journal of Clinical Endocrinology & Metabolism, Bind 105, Nr. 6, 2020, s. 1868-1877.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Albrethsen, J, Johannsen, TH, Jørgensen, N, Frederiksen, H, Sennels, HP, Jorgensen, HL, Fahrenkrug, J, Petersen, JH, Linneberg, A, Nordkap, L, Bang, AK, Andersson, A-M & Juul, A 2020, 'Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function', Journal of Clinical Endocrinology & Metabolism, bind 105, nr. 6, s. 1868-1877. https://doi.org/10.1210/clinem/dgaa145

APA

Albrethsen, J., Johannsen, T. H., Jørgensen, N., Frederiksen, H., Sennels, H. P., Jorgensen, H. L., Fahrenkrug, J., Petersen, J. H., Linneberg, A., Nordkap, L., Bang, A. K., Andersson, A-M., & Juul, A. (2020). Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function. Journal of Clinical Endocrinology & Metabolism, 105(6), 1868-1877. https://doi.org/10.1210/clinem/dgaa145

Vancouver

Albrethsen J, Johannsen TH, Jørgensen N, Frederiksen H, Sennels HP, Jorgensen HL o.a. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function. Journal of Clinical Endocrinology & Metabolism. 2020;105(6):1868-1877. https://doi.org/10.1210/clinem/dgaa145

Author

Albrethsen, Jakob ; Johannsen, Trine Holm ; Jørgensen, Niels ; Frederiksen, Hanne ; Sennels, Henriette P. ; Jorgensen, Henrik Loevendahl ; Fahrenkrug, Jan ; Petersen, Jorgen Holm ; Linneberg, Allan ; Nordkap, Loa ; Bang, Anne Kirstine ; Andersson, Anna-Maria ; Juul, Anders. / Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function. I: Journal of Clinical Endocrinology & Metabolism. 2020 ; Bind 105, Nr. 6. s. 1868-1877.

Bibtex

@article{0e8f7c17da024322a4e76619e6fa7f9a,
title = "Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function",
abstract = "Background: The peptide hormone insulin-like factor 3 (INSL3) is a marker for Leydig cell function and the clinical use of serum INSL3 measurements has been suggested by several groups.Aim: (1) To establish a reference range for liquid chromatography-tandem mass spectrometry (LC-MS/MS) of serum INSL3 in healthy boys and men; and (2) to compare the associations of serum INSL3 and testosterone (T) to pubertal stage, lifestyle factors, diurnal variation, body composition, and human chorionic gonadotropin (hCG) stimulation.Results: In a reference range based on LC-MS/MS analysis of serum from 1073 boys and men, INSL3 increased from levels close to the detection limit (0.03 mu g/L) in prepubertal boys to a maximum mean level of 1.3 mu g/L (95% CI, 0.9-2.7) in young men (19-40 years of age) and decreased slightly in older men (0.1 mu g/L per decade). Serum T, but not INSL3, was associated with body mass index or body fat percentage and with alcohol consumption. Smoking was positively associated with serum T, but negatively associated with INSL3. There were significant diurnal variations in both INSL3 and T in men (P <0.001), but serum INSL3 varied substantially less, compared with serum T (+/- 11% vs +/- 26%). Mean serum INSL3 increased after hCG stimulation, but less than T (+ 17% vs +/- 53%), In both healthy men and in patients suspected of testicular failure, baseline serum INSL3 was more closely associated to the hCG-induced increase in serum T than baseline T itself.Conclusion: Measurement of serum INSL3 by LC-MS/MS has promise as a marker of testicular disorders.",
keywords = "INSL3, testosterone, normal range, diurnal variation, Leydig cell, LC-MS/MS, LIFE-STYLE FACTORS, HEALTHY BOYS, TESTOSTERONE, MEN, AGE, ASSOCIATIONS, DECLINE, HORMONE",
author = "Jakob Albrethsen and Johannsen, {Trine Holm} and Niels J{\o}rgensen and Hanne Frederiksen and Sennels, {Henriette P.} and Jorgensen, {Henrik Loevendahl} and Jan Fahrenkrug and Petersen, {Jorgen Holm} and Allan Linneberg and Loa Nordkap and Bang, {Anne Kirstine} and Anna-Maria Andersson and Anders Juul",
year = "2020",
doi = "10.1210/clinem/dgaa145",
language = "English",
volume = "105",
pages = "1868--1877",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

AU - Albrethsen, Jakob

AU - Johannsen, Trine Holm

AU - Jørgensen, Niels

AU - Frederiksen, Hanne

AU - Sennels, Henriette P.

AU - Jorgensen, Henrik Loevendahl

AU - Fahrenkrug, Jan

AU - Petersen, Jorgen Holm

AU - Linneberg, Allan

AU - Nordkap, Loa

AU - Bang, Anne Kirstine

AU - Andersson, Anna-Maria

AU - Juul, Anders

PY - 2020

Y1 - 2020

N2 - Background: The peptide hormone insulin-like factor 3 (INSL3) is a marker for Leydig cell function and the clinical use of serum INSL3 measurements has been suggested by several groups.Aim: (1) To establish a reference range for liquid chromatography-tandem mass spectrometry (LC-MS/MS) of serum INSL3 in healthy boys and men; and (2) to compare the associations of serum INSL3 and testosterone (T) to pubertal stage, lifestyle factors, diurnal variation, body composition, and human chorionic gonadotropin (hCG) stimulation.Results: In a reference range based on LC-MS/MS analysis of serum from 1073 boys and men, INSL3 increased from levels close to the detection limit (0.03 mu g/L) in prepubertal boys to a maximum mean level of 1.3 mu g/L (95% CI, 0.9-2.7) in young men (19-40 years of age) and decreased slightly in older men (0.1 mu g/L per decade). Serum T, but not INSL3, was associated with body mass index or body fat percentage and with alcohol consumption. Smoking was positively associated with serum T, but negatively associated with INSL3. There were significant diurnal variations in both INSL3 and T in men (P <0.001), but serum INSL3 varied substantially less, compared with serum T (+/- 11% vs +/- 26%). Mean serum INSL3 increased after hCG stimulation, but less than T (+ 17% vs +/- 53%), In both healthy men and in patients suspected of testicular failure, baseline serum INSL3 was more closely associated to the hCG-induced increase in serum T than baseline T itself.Conclusion: Measurement of serum INSL3 by LC-MS/MS has promise as a marker of testicular disorders.

AB - Background: The peptide hormone insulin-like factor 3 (INSL3) is a marker for Leydig cell function and the clinical use of serum INSL3 measurements has been suggested by several groups.Aim: (1) To establish a reference range for liquid chromatography-tandem mass spectrometry (LC-MS/MS) of serum INSL3 in healthy boys and men; and (2) to compare the associations of serum INSL3 and testosterone (T) to pubertal stage, lifestyle factors, diurnal variation, body composition, and human chorionic gonadotropin (hCG) stimulation.Results: In a reference range based on LC-MS/MS analysis of serum from 1073 boys and men, INSL3 increased from levels close to the detection limit (0.03 mu g/L) in prepubertal boys to a maximum mean level of 1.3 mu g/L (95% CI, 0.9-2.7) in young men (19-40 years of age) and decreased slightly in older men (0.1 mu g/L per decade). Serum T, but not INSL3, was associated with body mass index or body fat percentage and with alcohol consumption. Smoking was positively associated with serum T, but negatively associated with INSL3. There were significant diurnal variations in both INSL3 and T in men (P <0.001), but serum INSL3 varied substantially less, compared with serum T (+/- 11% vs +/- 26%). Mean serum INSL3 increased after hCG stimulation, but less than T (+ 17% vs +/- 53%), In both healthy men and in patients suspected of testicular failure, baseline serum INSL3 was more closely associated to the hCG-induced increase in serum T than baseline T itself.Conclusion: Measurement of serum INSL3 by LC-MS/MS has promise as a marker of testicular disorders.

KW - INSL3

KW - testosterone

KW - normal range

KW - diurnal variation

KW - Leydig cell

KW - LC-MS/MS

KW - LIFE-STYLE FACTORS

KW - HEALTHY BOYS

KW - TESTOSTERONE

KW - MEN

KW - AGE

KW - ASSOCIATIONS

KW - DECLINE

KW - HORMONE

U2 - 10.1210/clinem/dgaa145

DO - 10.1210/clinem/dgaa145

M3 - Journal article

C2 - 32211773

VL - 105

SP - 1868

EP - 1877

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -

ID: 246779212